Edwards Lifesciences (EW) vs Zimmer Biomet (ZBH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Edwards Lifesciences (EW) has outperformed Zimmer Biomet (ZBH) over the past year, gaining 11.8% versus a loss of 10.7%. Over five years, EW leads with a -23.5% price change compared with -37.7% for ZBH. Edwards Lifesciences is the larger company by market cap ($48.44 billion vs $16.96 billion), about 2.9 times the size.
On valuation, Zimmer Biomet trades at a lower forward P/E (9.8x vs 24.8x for Edwards Lifesciences). Zimmer Biomet pays a dividend yielding 1.08%, while Edwards Lifesciences does not currently pay one. Edwards Lifesciences converts more of its revenue into profit, with a net margin of 17.7% versus 8.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EW | ZBH |
|---|---|---|
| Share price | $84.05 | $88.94 |
| Market cap | $48.44B | $16.96B |
| 1-day change | -2.02% | +0.51% |
| YTD return | +0.62% | -1.59% |
| 1-year return | +11.81% | -10.67% |
| 5-year return | -23.52% | -37.73% |
| P/E ratio (TTM) | 50.03 | 21.59 |
| Forward P/E | 24.84 | 9.81 |
| EPS (TTM) | $1.68 | $4.12 |
| Dividend yield | 0.00% | 1.08% |
| Annual dividend | $0.00 | $0.96 |
| Revenue (latest FY) | $6.07B | $8.23B |
| Revenue growth (YoY) | +11.55% | +7.20% |
| Net income (latest FY) | $1.07B | $705.10M |
| Gross margin | 78.01% | 69.71% |
| Operating margin | 20.84% | 13.34% |
| Net margin | 17.69% | 8.57% |
| 52-week high | $96.29 | $106.88 |
| 52-week low | $72.30 | $79.12 |
| Distance from 52-week high | -12.72% | -16.79% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +21.32% | +20.56% |
| Average volume | 3.82M | 2.16M |
| Shares outstanding | 576.40M | 190.74M |
| Employees | 16,000 | 17,000 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Edwards Lifesciences is about 2.9 times larger than Zimmer Biomet by market value ($48.44B vs $16.96B).
- EW has outperformed ZBH by 22.5 percentage points over the past year.
- Edwards Lifesciences trades at a higher earnings multiple (50.0x vs 21.6x trailing P/E).
- Zimmer Biomet offers a meaningfully higher dividend yield (1.08% vs 0.00%).
- Edwards Lifesciences is more profitable, keeping 17.7 cents of every revenue dollar as net income versus 8.6 cents for Zimmer Biomet.
About Edwards Lifesciences
EW stock →Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands.
Health Care · Industrial Specialties · 16,000 employees
About Zimmer Biomet
ZBH stock →Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.
Health Care · Industrial Specialties · 17,000 employees
EW vs ZBH FAQ
Which is bigger, Edwards Lifesciences or Zimmer Biomet?
Edwards Lifesciences (EW) is larger, with a market capitalization of $48.44B compared with $16.96B for Zimmer Biomet (ZBH).
Which stock has performed better over the past year, EW or ZBH?
EW returned +11.81% over the past 12 months, compared with -10.67% for ZBH (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, EW or ZBH?
ZBH has the lower trailing P/E at 21.6, versus 50.0 for EW. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Edwards Lifesciences or Zimmer Biomet?
Zimmer Biomet pays a dividend yielding 1.08%, while Edwards Lifesciences does not currently pay a regular dividend.
Are Edwards Lifesciences and Zimmer Biomet in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.